Company Profile

Rothwell, Figg, Ernst & Manbeck, P.C.

Company Overview

Rothwell Figg is a forward-thinking, client-focused law firm practicing the convergence of intellectual property, litigation, and technology. An interdisciplinary team of scientists, engineers, and litigators, who think and operate with our clients as strategic partners, we provide a comprehensive range of IP and technology legal services for U.S. and international clients, from startups to multinationals, and in every imaginable industry. We have the bandwidth to handle the largest, most complex, high stakes matters in the most sophisticated and complex technology areas. We are passionate about empowering our clients to meet their business objectives through protecting, enforcing, and monetizing their IP and technology. And, we are adaptable, collaborative, and nimble, able to deliver valuable results in all matters, small and large.

By collaborating with our clients, we develop an understanding of their marketplace, the stage they are at in their businesses, and their goals. We then craft a strategic solution and apply our experience and judgment to produce results. Whether protecting, enforcing, or defending a client’s innovations, webring unrivaled judgement, unmatched knowledge, and an uncanny ability to see what’s coming next.

While Rothwell Figg’s physical footprint may be small, we proudly represent well-known companies in high-stakes matters. As longstanding intellectual property for The New York Times, we are co-counsel in their consequential lawsuit against Microsoft Corporation and OpenAI alleging copyright infringement by their general AI tools. We recently achieved a notable victory for Amgen in an ongoing patent infringement case arising under the Biologics Price Competition and Innovation Act (BPCIA) involving Amgen’s biosimilar version of Regeneron’s EYLEA® product. In what Fierce Pharma notes “could prove to be the biggest U.S. loss of exclusivity in the pharma industry this year,” we were successful in overcoming Regeneron’s attempted preliminary injunction of the biosimilar, and Pavblu launched in November 2024. For more information, please visit www.rothwellfigg.com.

Benefits

Rothwell Figg subsidizes 100% of the employee's medical, dental, vision, life, and disability insurance benefits.

Positions Available
Sort by:
  1. Position
  2. ▲ Date
  3. Location
Show All Details
  • 9 days ago

    Marketing & Business Development Manager

    Rothwell, Figg, Ernst & Manbeck, P.C. - Washington, DC, United States
    1. Save

    Rothwell Figg is seeking a Marketing Business Development Manager with 5+ years of relevant experience, preferably in the legal services industry. This position will be responsible for developing and executing strategic business development and marketing initiatives for the firm and its intellectual property (IP), litigation, and technology practices, with a focus on growing revenue, deepening key client relationships, and enhancing the firm s market profile and digital visibility. Candidates ...

    See full job description